Antiviral Strategies for Emerging Infectious Diseases

The pandemic caused by the unexpected emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has prompted an urgent need for therapeutics and a vaccine against this infectious disease. Explore Cayman's tools to support the needed research to understand emerging infectious diseases in this issue of the Cayman Currents. 

Cayman Currents Issue 33: Antiviral Strategies for Emerging Infectious Diseases. In this issue:

• Using Existing Therapeutics Against SARS-CoV-2
• SARS-CoV-2 Research Tools
• Antiviral Compounds & Libraries
• Vaccine Development Considerations
• Host Immune Response
• Immunopeptidome Profiling Services
• Special Feature: Viral Infection Life Cycle Infographic

Articles:

• Using Existing Therapeutics Against SARS-CoV-2
• Vaccine Development for Emerging Infectious Disease

Click here to open '​Cayman Currents Issue 33: Antiviral Strategies for Emerging Infectious Diseases'. Request a physical copy here.

Click here to open 'Viral infection life cycle centerfold'